Ryan Martins

Ryan Martins

Director of Finance/CFO at 89BIO, INC.

Net worth: 853 938 $ as of 2024-06-29

47 year
Finance
Health Technology
Consumer Services

Profile

Ryan Stephen Martins is currently the Chief Financial Officer at 89bio, Inc. He previously held positions at Chiron Corp., Lehman Brothers, Inc., Ultragenyx Pharmaceutical, Inc., Jefferies LLC, Barclays Capital, Inc., FM Partners Holdings LLC, and Revolution Medicines, Inc. He has a graduate degree from Virginia Polytechnic Institute & State University, undergraduate and graduate degrees from the University of Mumbai, an MBA from Haas School of Business, and an undergraduate degree from St. Xavier's College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-16 106,609 ( 0.11% ) 853 938 $ 2024-06-29

Ryan Martins active positions

CompaniesPositionStart
89BIO, INC. Director of Finance/CFO 2019-06-30
All active positions of Ryan Martins

Former positions of Ryan Martins

CompaniesPositionEnd
REVOLUTION MEDICINES, INC. Director of Finance/CFO 2018-09-30
ULTRAGENYX PHARMACEUTICAL INC. Investor Relations Contact 2018-02-28
Analyst-Equity 2015-06-30
Analyst-Equity 2014-01-30
Analyst-Equity -
See the detail of Ryan Martins's experience

Training of Ryan Martins

Virginia Polytechnic Institute & State University Graduate Degree
University of Mumbai Graduate Degree
Haas School of Business Masters Business Admin
St. Xavier's College Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ryan Martins's experience

Connections

100 +

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
ULTRAGENYX PHARMACEUTICAL INC.

Health Technology

89BIO, INC.

Health Technology

REVOLUTION MEDICINES, INC.

Health Technology

Private companies5

Finance

Finance

Finance

Health Technology

Finance

See company connections